Avinger, Inc. (AVGR)
USD 0.47
(-20.74%)
USD 0.47
(-20.74%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -18.32 Million USD | -5.12% |
| 2022 | -17.42 Million USD | 15.85% |
| 2021 | -20.71 Million USD | -4.47% |
| 2020 | -19.82 Million USD | -0.36% |
| 2019 | -19.75 Million USD | 28.33% |
| 2018 | -27.55 Million USD | 43.45% |
| 2017 | -48.73 Million USD | 13.18% |
| 2016 | -56.12 Million USD | -18.55% |
| 2015 | -47.34 Million USD | -48.12% |
| 2014 | -31.96 Million USD | 19.89% |
| 2013 | -39.9 Million USD | -17.83% |
| 2012 | -33.86 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -4.36 Million USD | 20.94% |
| 2024 Q1 | -5.51 Million USD | -9.81% |
| 2023 Q4 | -5.02 Million USD | -146.27% |
| 2023 FY | -18.32 Million USD | -5.12% |
| 2023 Q2 | -4.17 Million USD | 9.96% |
| 2023 Q1 | -4.63 Million USD | -12.6% |
| 2023 Q3 | -2.04 Million USD | 51.15% |
| 2022 FY | -17.42 Million USD | 15.85% |
| 2022 Q4 | -4.11 Million USD | 8.34% |
| 2022 Q3 | -4.49 Million USD | 15.86% |
| 2022 Q2 | -5.34 Million USD | 4.35% |
| 2022 Q1 | -5.58 Million USD | -11.77% |
| 2021 FY | -20.71 Million USD | -4.47% |
| 2021 Q2 | -2.45 Million USD | 51.46% |
| 2021 Q3 | -4.91 Million USD | -100.33% |
| 2021 Q1 | -5.05 Million USD | -9.11% |
| 2021 Q4 | -4.99 Million USD | -1.71% |
| 2020 Q2 | -4 Million USD | 31.64% |
| 2020 Q3 | -4.52 Million USD | -13.13% |
| 2020 Q1 | -5.85 Million USD | -14.26% |
| 2020 Q4 | -4.63 Million USD | -2.32% |
| 2020 FY | -19.82 Million USD | -0.36% |
| 2019 Q2 | -4.65 Million USD | 7.99% |
| 2019 FY | -19.75 Million USD | 28.33% |
| 2019 Q4 | -5.12 Million USD | -10.77% |
| 2019 Q3 | -4.62 Million USD | 0.6% |
| 2019 Q1 | -5.05 Million USD | 17.0% |
| 2018 Q3 | -5.38 Million USD | 7.09% |
| 2018 FY | -27.55 Million USD | 43.45% |
| 2018 Q4 | -6.09 Million USD | -13.03% |
| 2018 Q2 | -5.79 Million USD | 43.59% |
| 2018 Q1 | -10.28 Million USD | -1.29% |
| 2017 Q2 | -12.79 Million USD | 16.56% |
| 2017 Q4 | -10.15 Million USD | 2.81% |
| 2017 Q1 | -15.34 Million USD | -13.65% |
| 2017 FY | -48.73 Million USD | 13.18% |
| 2017 Q3 | -10.44 Million USD | 18.41% |
| 2016 Q4 | -13.49 Million USD | -4.07% |
| 2016 FY | -56.12 Million USD | -18.55% |
| 2016 Q3 | -12.96 Million USD | 3.9% |
| 2016 Q2 | -13.49 Million USD | 16.52% |
| 2016 Q1 | -16.16 Million USD | -20.15% |
| 2015 FY | -47.34 Million USD | -48.12% |
| 2015 Q2 | -10.22 Million USD | 1.89% |
| 2015 Q1 | -10.41 Million USD | -28.05% |
| 2015 Q4 | -13.45 Million USD | -1.55% |
| 2015 Q3 | -13.25 Million USD | -29.65% |
| 2014 Q2 | -7.07 Million USD | 11.2% |
| 2014 Q3 | -8.78 Million USD | -24.05% |
| 2014 Q4 | -8.13 Million USD | 7.35% |
| 2014 Q1 | -7.97 Million USD | 7.31% |
| 2014 FY | -31.96 Million USD | 19.89% |
| 2013 Q3 | -9.27 Million USD | 15.76% |
| 2013 Q2 | -11.01 Million USD | 0.0% |
| 2013 FY | -39.9 Million USD | -17.83% |
| 2013 Q1 | -11.01 Million USD | 0.0% |
| 2013 Q4 | -8.6 Million USD | 7.3% |
| 2012 FY | -33.86 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 71.069% |
| AngioDynamics, Inc. | -184.34 Million USD | 90.062% |
| AtriCure, Inc. | -30.43 Million USD | 39.812% |
| Azenta, Inc. | -14.25 Million USD | -28.498% |
| BioLife Solutions, Inc. | -66.42 Million USD | 72.421% |
| The Cooper Companies, Inc. | 294.2 Million USD | 106.227% |
| Daxor Corporation | 280.64 Thousand USD | 6627.936% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | -20.542% |
| Femasys Inc. | -14.24 Million USD | -28.587% |
| GlucoTrack, Inc. | -7.09 Million USD | -158.137% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -436.457% |
| Hologic, Inc. | 789.5 Million USD | 102.32% |
| ICU Medical, Inc. | -29.65 Million USD | 38.223% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 101.019% |
| KORU Medical Systems, Inc. | -13.74 Million USD | -33.323% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 160.854% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -174.934% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -174.934% |
| Masimo Corporation | 81.5 Million USD | 122.479% |
| Microbot Medical Inc. | -10.74 Million USD | -70.577% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 257.586% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 119.405% |
| Nephros, Inc. | -1.57 Million USD | -1063.175% |
| NovoCure Limited | -207.04 Million USD | 91.152% |
| NEXGEL, Inc. | -3.15 Million USD | -480.298% |
| NEXGEL, Inc. | -3.15 Million USD | -480.298% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 80.679% |
| OraSure Technologies, Inc. | 53.65 Million USD | 134.144% |
| Pro-Dex, Inc. | 2.12 Million USD | 961.307% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 56.598% |
| Predictive Oncology Inc. | -13.98 Million USD | -31.007% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -520.727% |
| QuidelOrtho Corporation | -10.1 Million USD | -81.386% |
| Repligen Corporation | 41.57 Million USD | 144.063% |
| Sanara MedTech Inc. | -4.3 Million USD | -325.73% |
| STAAR Surgical Company | 21.34 Million USD | 185.82% |
| Sharps Technology, Inc. | -9.84 Million USD | -86.148% |
| Utah Medical Products, Inc. | 16.63 Million USD | 210.129% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 86.121% |
| Jin Medical International Ltd. | 2.87 Million USD | 736.502% |